<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> is an important contributing mechanism in ischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>The current study elucidates a previously unexplored role of Fas ligand (FasL) in post-<z:hpo ids='HP_0001297'>stroke</z:hpo> <z:mp ids='MP_0001845'>inflammatory responses</z:mp> that is independent of its well-known effect in triggering <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced for 2 h by right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) in FasL mutant (gld) and <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="3" pm="."><plain>FasL mutation profoundly reduced brain damage and improved neurological performance from 6 to 72 h after <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The production of inflammatory cytokines in the brain was attenuated in gld mice after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the absence of dramatic change in inflammatory cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>FasL mutation attenuated the recruitment of peripheral inflammatory cells (neutrophil) and inhibited the activation of residential glial cells (microglia and astrocyte) </plain></SENT>
<SENT sid="6" pm="."><plain>FasL mutation reduced CD8(+) T cells and turned the Th1/Th2 balance towards Th2 in the brain and peripheral blood after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>In contrast to <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, the molecular and cellular inflammatory changes induced by intracerebroventricular injection of <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) were also attenuated in gld mice </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, the soluble FasL (sFasL) and phospho-SAPK/JNK were decreased in gld mice, suggesting that the inflammatory role of FasL in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo> might relate to sFasL and the c-Jun N-terminal kinase (JNK) signaling pathway </plain></SENT>
<SENT sid="9" pm="."><plain>Taken together, our data suggest a novel role of FasL in the damaging <z:mp ids='MP_0001845'>inflammatory responses</z:mp> associated with <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Neutralization of FasL may be a novel therapeutic strategy to suppress post-<z:hpo ids='HP_0001297'>stroke</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and improve the long-term outcomes of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>